ArticleTrials2024

A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program.

Brad Stanfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.